Menu
B

Barnet Dulaney Perkins Eye Center | Phoenix

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Riboflavin
RBX2660
OC-01
Faricimab
Ranibizumab
TNX-102
Abicipar Pegol
RO7446603
Aflibercept
Relugolix

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Active trials

A Phase 3, Randomized, Double-Masked, Active-Controlled Trial in Adults with Macular Neovascularization Secondary to Age-Related Macular Degeneration

Enrolling
Macular Neovascularization Secondary to Age-Related Macular Degeneration
Biological: 4D-150 IVT (3E10 vg/eye)
Biological: EYLEA® (aflibercept) Injection 2 mg (0.05mL)

The purpose of this clinical trial to characterize changes in bone mineral density during continuous treatment with relugolix combination tablet for...

Enrolling
Uterine Fibroids
Endometriosis
Drug: Relugolix Combination Tablet

This study aims to evaluate the ocular and systemic safety, tolerability and efficacy of RO7446603 in participants with diabetic macular edema (DME)....

Enrolling
Diabetic Macular Edema
Drug: Faricimab
Drug: Aflibercept

This study is designed to investigate treatment response in treatment-naïve underrepresented patients with diabetic macular edema (DME) who are treat...

Active, not recruiting
Diabetic Macular Edema
Drug: Faricimab

This study will evaluate the long-term safety and tolerability of the Port Delivery System with ranibizumab (PDS) (100 mg/mL) in participants with ne...

Enrolling
Neovascular Age-Related Macular Degeneration
Drug: PDS Implant with Ranibizumab 100 mg/mL

ABBV-RGX-314 is being developed as a novel, potential one-time gene therapy treatment for the treatment of Diabetic Retinopathy (DR) with and without...

Enrolling
Diabetic Retinopathy (DR)
Center-Involved Diabetic Macular Edema (CI-DME)
Genetic: ABBV-RGX-314 Dose 4
Biological: Aflibercept

The purpose of this study is to assess the contraceptive efficacy of relugolix combination therapy.

Active, not recruiting
Contraception
Drug: Relugolix Combination Therapy
Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trial sponsors

Topcon logo
Genentech logo
R
Sumitomo Pharma logo
Tonix Pharmaceuticals logo
4
AbbVie logo
Allergan logo
Bausch Health logo
D